Annual Interest Expense
$210.63 M
+$52.25 M+32.99%
31 December 2023
Summary:
Amneal Pharmaceuticals annual interest expense is currently $210.63 million, with the most recent change of +$52.25 million (+32.99%) on 31 December 2023. During the last 3 years, it has risen by +$64.63 million (+44.27%). AMRX annual interest expense is now at all-time high.AMRX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$65.51 M
-$208.00 K-0.32%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly interest expense is currently $65.51 million, with the most recent change of -$208.00 thousand (-0.32%) on 30 September 2024. Over the past year, it has increased by +$14.60 million (+28.68%). AMRX quarterly interest expense is now -0.32% below its all-time high of $65.72 million, reached on 30 June 2024.AMRX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$256.48 M
+$14.60 M+6.04%
30 September 2024
Summary:
Amneal Pharmaceuticals TTM interest expense is currently $256.48 million, with the most recent change of +$14.60 million (+6.04%) on 30 September 2024. Over the past year, it has increased by +$58.37 million (+29.46%). AMRX TTM interest expense is now at all-time high.AMRX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.0% | +28.7% | +29.5% |
| 3 y3 years | +44.3% | +90.4% | +87.3% |
| 5 y5 years | +46.7% | +55.2% | +48.9% |
AMRX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +54.5% | -0.3% | +96.5% | at high | +88.9% |
| 5 y | 5 years | at high | +54.5% | -0.3% | +96.5% | at high | +88.9% |
| alltime | all time | at high | +281.0% | -0.3% | +269.6% | at high | +1346.9% |
Amneal Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $65.51 M(-0.3%) | $256.48 M(+6.0%) |
| June 2024 | - | $65.72 M(+0.0%) | $241.88 M(+6.5%) |
| Mar 2024 | - | $65.70 M(+10.3%) | $227.02 M(+7.8%) |
| Dec 2023 | $210.63 M(+33.0%) | $59.55 M(+17.0%) | $210.63 M(+6.3%) |
| Sept 2023 | - | $50.91 M(+0.1%) | $198.11 M(+4.5%) |
| June 2023 | - | $50.86 M(+3.1%) | $189.59 M(+8.7%) |
| Mar 2023 | - | $49.31 M(+4.9%) | $174.36 M(+10.1%) |
| Dec 2022 | $158.38 M(+16.2%) | $47.03 M(+10.9%) | $158.38 M(+9.0%) |
| Sept 2022 | - | $42.39 M(+19.0%) | $145.31 M(+5.8%) |
| June 2022 | - | $35.62 M(+6.9%) | $137.31 M(+1.1%) |
| Mar 2022 | - | $33.34 M(-1.8%) | $135.78 M(-0.4%) |
| Dec 2021 | $136.32 M(-6.6%) | $33.96 M(-1.3%) | $136.32 M(-0.4%) |
| Sept 2021 | - | $34.40 M(+0.9%) | $136.90 M(-0.4%) |
| June 2021 | - | $34.08 M(+0.6%) | $137.40 M(-1.8%) |
| Mar 2021 | - | $33.88 M(-1.9%) | $139.98 M(-4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $146.00 M(-13.2%) | $34.53 M(-1.0%) | $146.00 M(-2.9%) |
| Sept 2020 | - | $34.90 M(-4.8%) | $150.29 M(-4.6%) |
| June 2020 | - | $36.67 M(-8.1%) | $157.61 M(-4.4%) |
| Mar 2020 | - | $39.90 M(+2.8%) | $164.82 M(-2.0%) |
| Dec 2019 | $168.21 M(+17.2%) | $38.83 M(-8.0%) | $168.21 M(-2.4%) |
| Sept 2019 | - | $42.21 M(-3.8%) | $172.26 M(-0.5%) |
| June 2019 | - | $43.89 M(+1.4%) | $173.06 M(+4.4%) |
| Mar 2019 | - | $43.28 M(+0.9%) | $165.80 M(+15.5%) |
| Dec 2018 | $143.57 M(+102.0%) | $42.88 M(-0.3%) | $143.57 M(+19.0%) |
| Sept 2018 | - | $43.02 M(+17.5%) | $120.65 M(+24.6%) |
| June 2018 | - | $36.62 M(+74.0%) | $96.85 M(+24.2%) |
| Mar 2018 | - | $21.05 M(+5.5%) | $77.95 M(+37.0%) |
| Dec 2017 | $71.06 M(+28.5%) | $19.96 M(+3.8%) | $56.90 M(+54.0%) |
| Sept 2017 | - | $19.22 M(+8.4%) | $36.94 M(+108.4%) |
| June 2017 | - | $17.73 M | $17.73 M |
| Dec 2016 | $55.28 M | - | - |
FAQ
- What is Amneal Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual interest expense year-on-year change?
- What is Amneal Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly interest expense year-on-year change?
- What is Amneal Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM interest expense year-on-year change?
What is Amneal Pharmaceuticals annual interest expense?
The current annual interest expense of AMRX is $210.63 M
What is the all time high annual interest expense for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual interest expense is $210.63 M
What is Amneal Pharmaceuticals annual interest expense year-on-year change?
Over the past year, AMRX annual interest expense has changed by +$52.25 M (+32.99%)
What is Amneal Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of AMRX is $65.51 M
What is the all time high quarterly interest expense for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly interest expense is $65.72 M
What is Amneal Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, AMRX quarterly interest expense has changed by +$14.60 M (+28.68%)
What is Amneal Pharmaceuticals TTM interest expense?
The current TTM interest expense of AMRX is $256.48 M
What is the all time high TTM interest expense for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM interest expense is $256.48 M
What is Amneal Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, AMRX TTM interest expense has changed by +$58.37 M (+29.46%)